Todd E. Simpson, Chief Financial Officer at SEATTLE GENETICS INC /WA (SGEN), sold 23,007 shares at $171.39 ($3.9M) on 2020-07-01, disclosed to the SEC on 2020-07-02.
Open-market sale of $3.9M SGEN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.86 | 1,300 | $216K | 5.6% |
| 2 | $165.86 | 1,300 | $216K | 5.6% |
| 3 | $166.99 | 4,112 | $687K | 17.8% |
| 4 | $166.99 | 4,112 | $687K | 17.8% |
| 5 | $167.66 | 5,012 | $840K | 21.8% |
| 6 | $167.66 | 5,012 |
| $840K |
| 21.8% |
| 7 | $170.18 | 139 | $24K | 0.6% |
| 8 | $171.39 | 1,010 | $173K | 4.5% |
| 9 | $171.39 | 1,010 | $173K | 4.5% |
| Total | $167.56 avg | 23,007 | $3.9M | 100% |
| Filing → |
| SGEN | SELL | 2023-08-30 | $100K | — | Filing → |
| SGEN | SELL | 2023-04-12 | $22.6M | — | Filing → |
| SGEN | SELL | 2023-04-07 | $100K | — | Filing → |